WO2023179905 - COMBINATION OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE AND A FUMARIC ACID ESTER
National phase entry:
Publication Number
WO/2023/179905
Publication Date
28.09.2023
International Application No.
PCT/EP2023/000022
International Filing Date
23.03.2023
Title **
[English]
COMBINATION OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE AND A FUMARIC ACID ESTER
[French]
COMBINAISON DE 5-AMINO-2,3-DIHYDRO -1,4-PHTALAZINEDIONE ET D'UN ESTER D'ACIDE FUMARIQUE
Applicants **
METRIOPHARM AG
Inventors
BRYSCH, Wolfgang
SCHUMANN, Sara
BREMBECK, Felix
LUDESCHER, Beate
VON WEGERER, Jörg
Priority Data
22000080.6
25.03.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2238 | |
| EPO | Filing, Examination, Granting | 6855 | |
| Japan | Filing, Examination, Granting | 2233 | |
| South Korea | Filing, Examination, Granting | 2110 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
18,176
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present application relates to a combination of 5-amino-2,3-dihydro-1,4- phthalazinedione or one of its pharmaceutically acceptable salts and at least one fumaric acid ester or a pharmaceutically acceptable salt thereof. In particular, the invention relates to the use of 5-amino-2,3-dihydro-1,4-phthalazinedione sodium salt in said pharmaceutical combination. Pharmaceutical compositions and advantageous formulation techniques are disclosed.[French]
La présente invention concerne une combinaison de 5-amino-2,3-dihydro -1,4-phtalazinedione ou d'un de ses sels pharmaceutiquement acceptables et d'au moins un ester d'acide fumarique ou d'un sel pharmaceutiquement acceptable de celui-ci. En particulier, l'invention concerne l'utilisation de sel de sodium de 5-amino-2,3-dihydro -1,4-phtalazinedione dans ladite combinaison pharmaceutique. L'invention concerne également des compositions pharmaceutiques et des techniques de formulation avantageuses.